Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Май 10, 2024
Hepatocellular
carcinoma
(HCC)
is
a
significant
contributor
to
cancer-related
deaths
in
the
world.
The
development
and
progression
of
HCC
are
closely
correlated
with
abnormal
regulation
non-coding
RNAs
(ncRNAs),
such
as
microRNAs
(miRNAs),
long
(lncRNAs),
circular
(circRNAs).
Important
biological
pathways
cancer
biology,
cell
proliferation,
death,
metastasis,
impacted
by
these
ncRNAs,
which
modulate
gene
expression.
expression
raises
possibility
that
they
could
be
applied
new
biomarkers
for
diagnosis,
prognosis,
treatment
targets.
Furthermore,
controlling
genes,
miRNAs
can
function
either
tumor
suppressors
or
oncogenes.
On
other
hand,
lncRNAs
play
role
advancement
interacting
molecules
within
cell,
which,
turn,
affects
processes
chromatin
remodeling,
transcription,
post-transcriptional
processes.
importance
ncRNA-driven
regulatory
systems
being
highlighted
current
research,
sheds
light
on
behavior
therapy
response.
This
research
highlights
great
potential
ncRNAs
improve
patient
outcomes
this
difficult
disease
landscape
augmenting
present
methods
care
through
use
precision
medicine
approaches.
Язык: Английский
Crosstalk between m6A modification and non-coding RNAs in HCC
Cellular Signalling,
Год журнала:
2024,
Номер
117, С. 111076 - 111076
Опубликована: Фев. 2, 2024
Язык: Английский
A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma—From m6A Modification to Blood Biomarkers
Cells,
Год журнала:
2023,
Номер
12(18), С. 2272 - 2272
Опубликована: Сен. 14, 2023
With
recent
advancements
in
biological
research,
long
non-coding
RNAs
(lncRNAs)
with
lengths
exceeding
200
nucleotides
have
emerged
as
pivotal
regulators
of
gene
expression
and
cellular
phenotypic
modulation.
Despite
initial
skepticism
due
to
their
low
sequence
conservation
levels,
significance
various
processes
has
become
increasingly
apparent.
We
provided
an
overview
lncRNAs
discussed
defining
features
modes
operation.
then
explored
crucial
function
the
hepatocarcinogenesis
process,
elucidating
complex
involvement
hepatocellular
carcinoma
(HCC).
The
influential
role
within
HCC
tumor
microenvironment
is
emphasized,
illustrating
potential
key
modulators
disease
dynamics.
also
investigated
significant
influence
N6-methyladenosine
(m6A)
modification
on
lncRNA
HCC,
enhancing
our
understanding
both
roles
upstream
regulators.
Additionally,
promising
biomarkers
was
liver
cancer
diagnosis,
suggesting
a
novel
avenue
for
future
research
clinical
application.
Finally,
work
underscored
dual
contributors
pathogenesis
innovative
tools
its
diagnosis.
Existing
challenges
prospective
trajectories
are
discussed,
emphasizing
advancing
research.
Язык: Английский
Insight into the regulatory mechanism of m6A modification: From MAFLD to hepatocellular carcinoma
Xuan Zha,
Zewei Gao,
Min Li
и другие.
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
177, С. 116966 - 116966
Опубликована: Июнь 20, 2024
In
recent
years,
there
has
been
a
significant
increase
in
the
incidence
of
metabolic-associated
fatty
liver
disease
(MAFLD),
which
attributed
to
increasing
prevalence
type
2
diabetes
mellitus
(T2DM)
and
obesity.
MAFLD
affects
more
than
one-third
adults
worldwide,
making
it
most
prevalent
globally.
Moreover,
is
considered
risk
factor
for
hepatocellular
carcinoma
(HCC),
with
MAFLD-related
HCC
cases
increasing.
Approximately
1
6
patients
are
believed
have
MAFLD,
nearly
40
%
these
do
not
progress
cirrhosis,
indicating
direct
transformation
from
HCC.
N6-methyladenosine
(m
Язык: Английский
Deciphering the nexus between long non-coding RNAs and endoplasmic reticulum stress in hepatocellular carcinoma: biomarker discovery and therapeutic horizons
Cell Death Discovery,
Год журнала:
2024,
Номер
10(1)
Опубликована: Окт. 24, 2024
Hepatocellular
carcinoma
(HCC)
remains
a
significant
global
health
challenge
with
few
effective
treatment
options.
The
dysregulation
of
endoplasmic
reticulum
(ER)
stress
responses
has
emerged
as
pivotal
factor
in
HCC
progression
and
therapy
resistance.
Long
non-coding
RNAs
(lncRNAs)
play
crucial
role
key
epigenetic
modifiers
this
process.
Recent
research
explored
how
lncRNAs
influence
ER
which
turn
affects
activity
HCC.
We
systematically
analyze
the
current
literature
to
highlight
regulatory
roles
modulating
vice
versa
Our
scrutinization
highlights
dysregulated
contribute
various
facets
HCC,
including
apoptosis
resistance,
enhanced
proliferation,
invasion,
metastasis,
all
driven
by
stress.
Moreover,
we
delve
into
emerging
paradigm
lncRNA-miRNA-mRNA
axis,
elucidating
it
promising
avenue
for
developing
novel
biomarkers
paving
way
more
personalized
options
Nevertheless,
acknowledge
challenges
future
directions
translating
these
insights
clinical
practice.
In
conclusion,
our
review
provides
complex
mechanisms
governing
modulation
Язык: Английский
The epigenetic regulatory network of long noncoding RNAs in hepatocellular carcinoma
Genes & Diseases,
Год журнала:
2025,
Номер
unknown, С. 101534 - 101534
Опубликована: Янв. 1, 2025
Язык: Английский
Emerging importance of m6A modification in liver cancer and its potential therapeutic role
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,
Год журнала:
2025,
Номер
unknown, С. 189299 - 189299
Опубликована: Март 1, 2025
Язык: Английский
Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing KIAA1522
Asia-Pacific Journal of Clinical Oncology,
Год журнала:
2024,
Номер
20(3), С. 423 - 432
Опубликована: Март 23, 2024
Pancreatic
cancer
(PC)
has
a
poor
prognosis
and
high
mortality.
Kruppel-like
factor
9
(KLF9),
transcription
factor,
is
aberrantly
expressed
in
various
neoplasms.
The
current
study
sought
to
analyze
the
functional
role
of
KLF9
proliferation,
invasion,
migration
PC
cells.
Язык: Английский